LONDON (MarketWatch) -- Solvay Pharmaceuticals on Monday said it has obtained market authorization for Duodopa, a treatment for advanced Parkinson's disease in 28 European countries. The product was ...

Previous studies have shown that, compared with oral levodopa medication, continuous infusion of levodopa–carbidopa (duodopa) gel reduces motor complications in advanced Parkinson disease (PD). A ...

This combination medication contains antidyskinetic drugs, prescribed for Parkinson’s disease. The addition of Carbidopa enhances lower dose of Levodopa to be used. The information provided on this ...

1:51 Parkinson’s patients want funding for expensive drug The growing number of B.C. families calling for the province to reconsider it’s decision not to cover a pricey treatment for some living with ...

A Falklands veteran whose life was transformed by a Parkinson’s wonder drug has slammed a decision to restrict its use in Scotland. The Scottish Medicines Consortium yesterday rejected the drug ...

- Final data from the 12-week DYSCOVER study, the first randomized trial of DUODOPA® (levodopa/carbidopa intestinal gel) on the duration and severity of dyskinesia in patients with advanced ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Patti Wood has ...

AbbVie, a research-based global biopharmaceutical company, announced experts in the neuroscience field will present results from two late-breaking abstracts, including final data from the phase 1b ...

AbbVie’s bid to cannibalize its own Parkinson’s disease business has advanced, with the phase 3 success of subcutaneous, pump-delivered levodopa-carbidopa formulation ABBV-951 providing the backbone ...